Kidney Carcinoma clinical trials

Explore recruiting kidney carcinoma clinical trials.

Recruiting kidney carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

RUBIKID - Dynamic 82-Rb positron emission tomography (PET) for the grading of KIDney carcinoma

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Kidney Carcinoma trials by city

Kidney Carcinoma in Toronto Kidney Carcinoma in Vancouver Kidney Carcinoma in Montreal Kidney Carcinoma in Calgary Kidney Carcinoma in Edmonton Kidney Carcinoma in Ottawa Kidney Carcinoma in Winnipeg Kidney Carcinoma in Quebec City Kidney Carcinoma in Hamilton Kidney Carcinoma in Kitchener Kidney Carcinoma in London Kidney Carcinoma in Halifax Kidney Carcinoma in New York Kidney Carcinoma in Los Angeles Kidney Carcinoma in Chicago Kidney Carcinoma in Houston

Kidney Carcinoma clinical trials

Recruiting kidney carcinoma studies right now

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors

Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management

Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Also recruiting in Europe

RUBIKID - Dynamic 82-Rb positron emission tomography (PET) for the grading of KIDney carcinoma

Kidney Carcinoma trials by city

Other conditions